Omeprazole Market

1. Analysis of Omeprazole Market[R1] Size by Research Nester Reveals the Market to Grow with a CAGR of ~6% During 2023-2035 and Attain ~USD 4 Billion by 2035 Research Nester assesses the growth and market size of the global omeprazole market which is anticipated to be on account of the growing cases of chronic diseases globally. New York – October 10, 2022[SD2] - Research Nester’s recent market research analysis on “Omeprazole Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitor’s analysis and a detailed overview of the global omeprazole market in terms of market segmentation by dosage form, indication, distribution channel, and by region.

2. Increasing Cases of Gastroesophageal Reflux to Promote Global Market Share of Omeprazole Omeprazole is a prescribed proton pump inhibitor (PPI) that aids in reducing acidity. Due to its effective results, this drug has been approved by regulatory agencies in order to cure heartburns as well as for the treatment of gastroesophageal reflux. apart from the elderly population gastroesophageal reflux can affect youngsters as well which is boosting the growth of the omeprazole market. Positive results during the clinical trials of omeprazole in H. pylori elimination therapy are anticipated to increase the demand for omeprazole globally during the foreseen period. In order to treat Helicobacter pylori infection, RedHill Biopharma, for example, recently published the phase 3 findings of the Talicia capsule, which combines antibiotics and a proton pump inhibitor. Some of the major growth factors and challenges that are associated with the growth of the global omeprazole market are: Growth Drivers: Rising Awareness among People · Increasing Prevalence of Duodenal Ulcers [R3] · Challenges: Pantoprazole, lansoprazole, and esomeprazole are some of the alternative drugs of Omeprazole which are used widely around the world. Due to these

3. alternatives in the market, the growth of the omeprazole market is expected to be hampered. There are many side effects of omeprazole such as severe stomach ache, diarrhea, seizure, kidney problems, low magnesium, and symptoms of lupus. Serious side effects may follow up with clostridium difficile infection and allergic reactions. These factors may hinder the market growth of omeprazole. Access our detailed report at: https://www.researchnester.com/reports/omeprazole-market/2 477 By indication, the global Omeprazole market is segmented into four parts i.e., Duodenal Ulcer, Gastric Ulcer, Gastroesophageal Reflux, and Erosive Esophagitis. Among the four, the duodenal ulcer category is expected to drive the market growth. This category was leading the market in 2017 as well. Duodenal ulcers are most commonly observed in the age groups of 25-55 years. With age, the incidence of peptic ulcer increased to a peak of 28.8% in the 5th decade of life. By region, the North America Omeprazole market is to generate the largest share of the market. In 2020 the region experienced the prevalence of H. pylori infection which causes ulcers. Additionally, peptic ulcers are prominent in the US, around 4.5 million individuals are affected yearly. Also, about 10% of the US population is affected by duodenal ulcers. For example, there is an online service that helps people save around 80% on

4. their prescription costs by working with large pharmacies in the US. These key factors are bolstering the market growth of Omeprazole in the region. The fastest growth will be seen in Asia Pacific during the forecast period. Market growth in the region is driven by greater awareness amongst target audiences about treating this condition, growing incidences, and intensified focus of key market players to increase their product portfolio. Vonoprazan, a product that is FDA cleared for the treatment of gastroesophageal reflux disease by Phantom Pharmaceutics, has been made available to Japanese consumers and other Asian country in March 2022. In addition, with the increased demand for gastroesophageal disease treatment in the Asia region, a number of players have been expanding their presence there. This report also provides the existing competitive scenario of some of the key players of the global Omeprazole market which includes company profiling of Boehringer Ingelheim, AstraZeneca Plc., Azurity Pharma, Perrigo Company Plc, Salix Pharmaceuticals, Mochida Pharmaceutical Co., Ltd., Yoshindo Inc, Fuji Pharma Co., Ltd, Otsuka Pharmaceutical Co., Ltd, Takeda Pharmaceuticals Co., Ltd, and others. Request Report Sample@ https://www.researchnester.com/sample-request-2477 Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon,

5. provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties. Contact for more Info: AJ Daniel Email: info@researchnester.com U.S. Phone: +1 646 586 9123 U.K. Phone: +44 203 608 5919